Alterna Therapeutics Overview

  • Founded
  • 2015

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Alterna Therapeutics General Information


Developer of therapeutics intended to treat diabetes and obesity. The company's therapeutics target fat tissues that are known to limit inflammation and SHIP enzyme for the treatment of obesity, enabling patients to control obesity without any side effects.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Primary Office
  • 201 West Main Street
  • Suite 300, PMB 317
  • Durham, NC 27701
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alterna Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Sep-2018 Completed Out of Business
1. Seed Round 15-Nov-2015 Completed Startup
To view Alterna Therapeutics’s complete valuation and funding history, request access »